Product Code: ETC13236707 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Antiparasitic Market was valued at USD 1.8 Billion in 2024 and is expected to reach USD 4.1 Billion by 2031, growing at a compound annual growth rate of 12.90% during the forecast period (2025-2031).
The Global Antiparasitic Market is a rapidly growing sector driven by the increasing prevalence of parasitic infections worldwide. With a focus on preventing and treating diseases caused by parasites such as malaria, leishmaniasis, and helminth infections, the market encompasses a wide range of pharmaceuticals, including antiprotozoal drugs, antihelminthic drugs, and insecticides. Factors such as rising awareness about parasitic diseases, improved healthcare infrastructure, and ongoing research and development activities contribute to market expansion. Geographically, the market is segmented into regions like North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Key players in the industry are investing in innovative product development and strategic partnerships to gain a competitive edge in this dynamic market.
The Global Antiparasitic Market is experiencing significant growth due to the increasing prevalence of parasitic infections, particularly in developing countries. The market is witnessing a shift towards more effective and safer antiparasitic drugs, as well as the development of novel treatment options. There is a growing focus on research and development of new antiparasitic drugs, including combination therapies and vaccines. With the rise in pet ownership and livestock farming, the demand for antiparasitic products for animals is also on the rise. Additionally, the increasing awareness about parasitic diseases and the efforts to control and prevent them present opportunities for market expansion. Collaborations between pharmaceutical companies and research institutions, as well as government initiatives to combat parasitic infections, are driving the growth of the Global Antiparasitic Market.
The Global Antiparasitic Market faces several challenges, including increasing resistance to existing drugs among parasites, especially in regions with high parasite burden. Regulatory hurdles, such as lengthy approval processes for new antiparasitic drugs, can also hinder market growth. Limited awareness among healthcare professionals and patients about the importance of antiparasitic treatments and prevention measures is another challenge. Additionally, the high cost of some antiparasitic medications may restrict access for patients in low-income countries. Ensuring proper diagnosis and treatment of parasitic infections, along with developing innovative and cost-effective antiparasitic therapies, are key areas that the industry needs to address to overcome these challenges and drive market expansion.
The Global Antiparasitic Market is primarily driven by the increasing prevalence of parasitic infections worldwide, particularly in developing countries with poor sanitation and hygiene standards. The rise in awareness about parasitic diseases and the importance of preventive measures among healthcare professionals and the general population is also fueling market growth. Additionally, the growing investments in research and development activities to introduce advanced antiparasitic drugs with improved efficacy and safety profiles are driving market expansion. Furthermore, the increasing pet ownership and the consequent demand for antiparasitic products for companion animals are contributing to market growth. Overall, the market is expected to continue growing due to the persistent burden of parasitic infections and the continuous efforts to develop innovative solutions to combat them.
Government policies related to the Global Antiparasitic Market vary across countries, but generally, regulatory agencies such as the FDA in the United States and the European Medicines Agency in the EU play a key role in approving antiparasitic drugs for use. These agencies set guidelines for the development, approval, and marketing of antiparasitic products to ensure their safety, efficacy, and quality. Additionally, many governments have programs in place to control and prevent the spread of parasitic diseases, which may involve initiatives such as mass drug administration, surveillance programs, and public awareness campaigns. Overall, government policies aim to promote the availability of effective antiparasitic treatments while safeguarding public health and addressing the challenges posed by parasitic infections globally.
The Global Antiparasitic Market is expected to witness steady growth in the coming years, driven by the increasing prevalence of parasitic infections worldwide. Factors such as rising awareness about parasitic diseases, improved healthcare infrastructure, and the development of novel antiparasitic drugs are anticipated to fuel market expansion. Additionally, the growing demand for animal healthcare products to combat parasites in livestock and pets is projected to contribute to market growth. Technological advancements in drug formulations and diagnostic techniques are likely to further boost market prospects. However, challenges such as drug resistance, stringent regulatory requirements, and limited access to healthcare in developing regions may hinder market growth to some extent. Overall, the Global Antiparasitic Market is poised for significant development opportunities in the foreseeable future.
In the global antiparasitic market, Asia is expected to witness significant growth due to the high prevalence of parasitic infections in countries like India and China. North America and Europe are anticipated to hold a substantial market share driven by the increasing pet ownership and rising awareness about the importance of parasite prevention among pet owners. The Middle East and Africa region is projected to experience steady growth with a focus on livestock parasitic control measures. Latin America is likely to see growth attributed to the presence of a large livestock population and the adoption of antiparasitic products in agriculture. Overall, the global antiparasitic market is poised for expansion across all regions, driven by factors such as increasing disposable income, rising healthcare expenditure, and growing awareness about parasitic diseases.
Global Antiparasitic Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Antiparasitic Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Antiparasitic Market Revenues & Volume, 2021 & 2031F |
3.3 Global Antiparasitic Market - Industry Life Cycle |
3.4 Global Antiparasitic Market - Porter's Five Forces |
3.5 Global Antiparasitic Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Antiparasitic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Global Antiparasitic Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Global Antiparasitic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Antiparasitic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Antiparasitic Market Trends |
6 Global Antiparasitic Market, 2021 - 2031 |
6.1 Global Antiparasitic Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Antiparasitic Market, Revenues & Volume, By Anthelmintics, 2021 - 2031 |
6.1.3 Global Antiparasitic Market, Revenues & Volume, By Antiprotozoals, 2021 - 2031 |
6.1.4 Global Antiparasitic Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Antiparasitic Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Antiparasitic Market, Revenues & Volume, By Giardiasis, 2021 - 2031 |
6.2.3 Global Antiparasitic Market, Revenues & Volume, By Trichuriasis, 2021 - 2031 |
6.2.4 Global Antiparasitic Market, Revenues & Volume, By Filariasis, 2021 - 2031 |
6.2.5 Global Antiparasitic Market, Revenues & Volume, By Neurocysticercosis, 2021 - 2031 |
6.2.6 Global Antiparasitic Market, Revenues & Volume, By Hydatid disease, 2021 - 2031 |
6.2.7 Global Antiparasitic Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Antiparasitic Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Antiparasitic Market, Revenues & Volume, By Hospital pharmacies, 2021 - 2031 |
6.3.3 Global Antiparasitic Market, Revenues & Volume, By Retail pharmacies, 2021 - 2031 |
6.3.4 Global Antiparasitic Market, Revenues & Volume, By Online pharmacies, 2021 - 2031 |
6.3.5 Global Antiparasitic Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Antiparasitic Market, Overview & Analysis |
7.1 North America Antiparasitic Market Revenues & Volume, 2021 - 2031 |
7.2 North America Antiparasitic Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Antiparasitic Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4 North America Antiparasitic Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.5 North America Antiparasitic Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Antiparasitic Market, Overview & Analysis |
8.1 Latin America (LATAM) Antiparasitic Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Antiparasitic Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Antiparasitic Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
8.4 Latin America (LATAM) Antiparasitic Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
8.5 Latin America (LATAM) Antiparasitic Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Antiparasitic Market, Overview & Analysis |
9.1 Asia Antiparasitic Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Antiparasitic Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Antiparasitic Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
9.4 Asia Antiparasitic Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
9.5 Asia Antiparasitic Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Antiparasitic Market, Overview & Analysis |
10.1 Africa Antiparasitic Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Antiparasitic Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Antiparasitic Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
10.4 Africa Antiparasitic Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
10.5 Africa Antiparasitic Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Antiparasitic Market, Overview & Analysis |
11.1 Europe Antiparasitic Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Antiparasitic Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Antiparasitic Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
11.4 Europe Antiparasitic Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
11.5 Europe Antiparasitic Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Antiparasitic Market, Overview & Analysis |
12.1 Middle East Antiparasitic Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Antiparasitic Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Antiparasitic Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Antiparasitic Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
12.4 Middle East Antiparasitic Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
12.5 Middle East Antiparasitic Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Antiparasitic Market Key Performance Indicators |
14 Global Antiparasitic Market - Export/Import By Countries Assessment |
15 Global Antiparasitic Market - Opportunity Assessment |
15.1 Global Antiparasitic Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Antiparasitic Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
15.3 Global Antiparasitic Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
15.4 Global Antiparasitic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Antiparasitic Market - Competitive Landscape |
16.1 Global Antiparasitic Market Revenue Share, By Companies, 2024 |
16.2 Global Antiparasitic Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |